Position in ROIV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,690,044
-$709,713 QoQ
Shares Held
104,268
-34.4% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#163
of 494 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Rafferty Asset Management, LLC holds $331,711,589 across 163 Biotechnology names. ROIV ranks #12 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
65,798 | $32,683,840 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
38,534 | $24,027,490 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
55,332 | $16,656,591 | |
| 4 | MRNA |
Moderna, Inc.
|
111,906 | $7,836,777 | |
| 5 | INCY |
Incyte Corp
|
44,663 | $5,062,997 | |
| 6 | APGE |
Apogee Therapeutics, Inc.
|
33,369 | $4,429,067 | |
| 7 | ORKA |
Oruka Therapeutics, Inc.
|
43,110 | $4,102,778 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
|
35,287 | $4,046,360 |
All Filings in ROIV
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,690,044 | 104,268 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,399,757 | 158,836 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,396,791 | 294,783 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $7,199,958 | 475,873 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $6,742,063 | 598,231 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $5,074,775 | 502,951 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $8,546,335 | 722,429 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $7,691,052 | 666,469 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $9,277,384 | 877,709 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $9,614,514 | 912,193 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $10,928,294 | 973,134 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $9,087,016 | 777,998 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $7,989,720 | 792,631 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $6,263,450 | 848,706 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $2,929,221 | 366,611 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $477,629 | 148,332 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $123,068 | 30,238 | Shares | Sole | 2022-08-12 | |
| No filing history on record for this holder in this stock. | ||||||